articleAnnals of OncologySep 12, 2012Closed access

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

HSHalfdan Sørbye SWStaffan Welin SWSeppo W. Langer LWLene Weber VestermarkNHN. Holt

Haukeland University Hospital · Uppsala University · +9 more institutions

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,020

total citations

FWCI: 22.24
Percentile: 100%
References: 38

Citations per year

Authors

20

HS
Halfdan SørbyeCorresponding
Haukeland University Hospital
SW
Staffan Welin
Uppsala University
SW
Seppo W. Langer
University of Copenhagen, Rigshospitalet
LW
Lene Weber Vestermark
Odense University Hospital
NH
N. Holt
Aarhus University Hospital

Topics & keywords

Topics

Keywords

Medicine
Neuroendocrine carcinoma
Internal medicine
Oncology
Carcinoma
Neuroendocrine tumors

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.